Sign up to get weekly articles on quality & compliance.

Data-Driven Medicine + Reducing Preventable Harm from Medications

May 31, 2017 / by Alexa Sussman

LS-Roundup-verse-small_2.jpgThis week’s roundup brings you the latest from the Life Sciences industry.

First, we see some big data developments for healthcare from the University of Chicago Medicine. Then, read up on the FDA’s efforts to reduce preventable adverse drug events. Finally, the Traqpath blog gives insight into managing Life Science compliance requirements in one central location for optimal results.

Happy reading!

Data-Driven Medicine
Author: Rob Mitchum via Quality Digest

Recently, the healthcare industry has seen ideas from big data make its way into clinical practice. The University of Chicago Medicine recently gave insight into 5 developments stemming from big data. They are:

  1. Data driven medicine
  2. Scaling up cancer research
  3. Special agents to help speed research
  4. Insight into statistics
  5. Data collection from home

Read the full article for details about these great developments.


Reducing Preventable Harm from Medications: Too Big for FDA to Do Alone
Author: John J. Whyte, MD, MPH via the FDA Voice Blog

It’s estimated that 1.5 million preventable adverse drug events take place in the US health care system each year. Challenges causing these issues include the current intricacies of our healthcare system, patients misunderstanding labels and manufacturers carefully crafting labels.

To work towards reducing or eliminating preventable injuries, illnesses and deaths, the FDA is hosting a symposium to gather patients, caregivers, prescribers, pharmacists, manufacturers, distributers and others to discuss factors that go into drug misuse and what can be done to prevent it.

Attendees will include:

  • Agencies like the FDA, the CDC and other drug and healthcare agencies.
  • State regulatory bodies
  • Healthcare insurers
  • Patient advocacy organizations

For more on this important event, read the post here.


The Benefits of Managing Your Compliance Requirements in A Centralized Location
Author: Emily Ysaguirre via the Traqpath Blog

The Life Sciences industry is highly regulated, so companies must achieve and maintain compliance to be successful. But with many moving parts, keeping information central and visible can be a challenge.

This post highlights some ways an automated, centralized system can help you better manage your compliance obligations. It includes benefits like:

  • Increase visibility and control
  • Better grounds for communication
  • Safer collaboration and improvement

Read on for even more ways centralizing your compliance obligations can help you.

Your Guidebook to Life Sciences

Topics: Top Stories, Topics: Life Sciences